146 related articles for article (PubMed ID: 33298249)
1. Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor.
Park HM; Kim H; Kim DW; Yoon JH; Kim BG; Cho JY
BMB Rep; 2020 Dec; 53(12):664-669. PubMed ID: 33298249
[TBL] [Abstract][Full Text] [Related]
2. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
[TBL] [Abstract][Full Text] [Related]
3. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
4. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
[TBL] [Abstract][Full Text] [Related]
5. Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer.
Liu D; Xiong H; Ellis AE; Northrup NC; Rodriguez CO; O'Regan RM; Dalton S; Zhao S
Cancer Res; 2014 Sep; 74(18):5045-56. PubMed ID: 25082814
[TBL] [Abstract][Full Text] [Related]
6. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
7. TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas.
Oliveira TF; Maués T; Ramundo MS; Figueiredo AMS; de Mello MFV; El-Jaick KB; Ferreira MLG; Ferreira AMR
J Vet Diagn Invest; 2017 Nov; 29(6):865-868. PubMed ID: 28754073
[TBL] [Abstract][Full Text] [Related]
8. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
9. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors.
Bergholtz H; Lien T; Lingaas F; Sørlie T
J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):171-183. PubMed ID: 35932380
[TBL] [Abstract][Full Text] [Related]
11. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J
Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231
[TBL] [Abstract][Full Text] [Related]
12. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
13. ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer.
Yan L; Gaddis S; Coletta LD; Repass J; Powell KL; Simper MS; Chen Y; Byrom M; Zhong Y; Lin K; Liu B; Lu Y; Shen J; MacLeod MC
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652981
[TBL] [Abstract][Full Text] [Related]
14. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of molecular markers in canine mammary tumors: correlation with histological grading.
Vinothini G; Balachandran C; Nagini S
Oncol Res; 2009; 18(5-6):193-201. PubMed ID: 20225757
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.
Carvalho MI; Silva-Carvalho R; Pires I; Prada J; Bianchini R; Jensen-Jarolim E; Queiroga FL
Biomed Res Int; 2016; 2016():4917387. PubMed ID: 28053982
[TBL] [Abstract][Full Text] [Related]
18. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
[TBL] [Abstract][Full Text] [Related]
19.
Schabort JJ; Nam AR; Lee KH; Kim SW; Lee JE; Cho JY
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218035
[TBL] [Abstract][Full Text] [Related]
20. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.
van Garderen E; Schalken JA
Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
